Literature DB >> 24321790

Future of fixed-dose longacting β2-agonist and antimuscarinic combination therapy in COPD.

Donald P Tashkin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24321790     DOI: 10.1016/S2213-2600(12)70055-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education.

Authors:  Claudio M Sanguinetti; Fernando De Benedetto; Claudio F Donner; Stefano Nardini; Alberto Visconti
Journal:  Multidiscip Respir Med       Date:  2014-06-12

Review 2.  Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease.

Authors:  Maria Gabriella Matera; Alessandro Sanduzzi; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.